Dr. Karolina Anna Kilowski, DO

Dr. Kilowski practices at AdventHealth Orlando in Orlando, Florida, part of AdventHealth.

Dr. Kilowski's NPI, 1649659145, was assigned on May 29, 2015. Dr. Kilowski graduated from Chicago College of Osteopathic Medicine at Midwestern University in 2015. Dr. Kilowski holds Texas license V4418.

Dr. Kilowski's primary practice is AdventHealth Orlando, at 601 E Rollins St, Orlando, FL 32803 in Orange County. The practice phone is (407) 303-1976.

Dr. Kilowski's primary practice is AdventHealth Orlando in Orlando, Florida, part of AdventHealth. Dr. Kilowski is also affiliated with Houston Methodist The Woodlands Hospital. The medical group on file is AdventHealth Medical Group. Dmand AI also links Dr. Kilowski to 2 more group practices and clinics and 2 medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Kilowski practices, 4 sites in all. Vendor and product names are available with a free account.

Gynecologic oncology is Dr. Kilowski's primary specialty in the NPI Registry, under taxonomy code 207VX0201X. Dr. Kilowski is board certified in 2019 - 2026 by the FL State License. Dmand AI has Dr. Kilowski's licenses on file in 2 states: Texas and Florida.

Dmand AI lists hysterectomy and ovarian cyst among the conditions Dr. Kilowski treats.

CMS data shows 159 Medicare services from Dr. Kilowski across 2 procedure codes in 2024, all of them office visits, for 76 Medicare patients. Medicare paid $13,679 for them. Every service was in an office.

CMS counts 76 Medicare patients who saw Dr. Kilowski in 2024. The largest group is 65 to 74, with 35 patients. 75% of them have high blood pressure, and 75% have high cholesterol. Their average risk score is 2.09, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Kilowski's median patient age at 71, with 99% women.

In 2024, Dr. Kilowski wrote 253 Medicare Part D claims for 64 patients. 94% of them were for generic drugs. CMS names the drug for 132 of them, across 5 drugs with 11 or more claims each, at $1,562 in total drug cost. In 2023, CMS named 85 claims across 4 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 100 out of 100 for Dr. Kilowski for performance year 2024, reported through an alternative payment model (APM). Dr. Kilowski accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Kilowski as offering telehealth. CMS counts 12 procedures of removal of the uterus by Dr. Kilowski, more than 86% of the clinicians it reports for that procedure.

Dmand AI links 6 papers to Dr. Kilowski, published from 2022 to 2025. 2022 was the busiest year, with 2. The most frequent topics are Endometrial Neoplasms. Dr. Kilowski has published most often in Gynecol Oncol. Dr. Kilowski's most frequent co-authors are Robert W. Holloway, MD, Nnamdi Ifekandu Gwacham, DO and Nadeem R. Abu-Rustum, MD.

CMS Open Payments shows 52 general payments to Dr. Kilowski from 26 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 97% of the total. AstraZeneca Pharmaceuticals LP paid the most, $773.

Dr. Kilowski graduated from Chicago College of Osteopathic Medicine at Midwestern University in 2015.

Dr. Kilowski is in network with 10 carriers, including Aetna, Excellus BlueCross BlueShield and Blue Cross Blue Shield of Michigan. Medicare plans come from the most carriers, 8. Check the plan with the practice before a visit.